ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,902Medicare Part D Prescriptions Filled, Including Refills

Rank: 383 out of 1456

$577K Total Retail Price of All Prescriptions

Rank: 359 out of 1456

590 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

3% of this provider’s 590 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 8,036 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
SIMVASTATIN 493 406 1 2
LEVOTHYROXINE SODIUM 449 387 2 4
LISINOPRIL 368 291 3 3
METFORMIN HCL 347 297 4 8
OMEPRAZOLE 309 252 5 5
CARVEDILOL 214 195 6 20
AMLODIPINE BESYLATE 212 183 7 1
LOSARTAN POTASSIUM 210 182 8 16
FUROSEMIDE 149 113 9 7
LISINOPRIL-HYDROCHLOROTHIAZIDE 142 125 10 24
AZITHROMYCIN 141 117 11 44
ATENOLOL 137 102 12 18
HYDROCHLOROTHIAZIDE 134 105 13 10
METOPROLOL TARTRATE 127 118 14 12
TAMSULOSIN HCL 126 108 15 34
ALLOPURINOL 124 108 16 31
ZOLPIDEM TARTRATE 122 95 17 14
TRAZODONE HCL 117 106 18 47
WARFARIN SODIUM 113 108 19 21
LOVASTATIN 112 95 20 40
LOSARTAN-HYDROCHLOROTHIAZIDE 111 111 21 41
SYNTHROID 107 102 22 37
ATORVASTATIN CALCIUM 104 76 23 11
NEXIUM 98 58 24 23
BYSTOLIC 95 78 25 102
MELOXICAM 95 80 25 30
GLIMEPIRIDE 86 63 27 33
PRAVASTATIN SODIUM 84 73 28 9
LEVOFLOXACIN 78 57 29 79
SERTRALINE HCL 73 63 30 25
FLUTICASONE PROPIONATE 73 66 30 28
AMLODIPINE BESYLATE-BENAZEPRIL 72 65 32 61
CITALOPRAM HBR 69 65 33 22
PLAVIX 66 65 34 46
NIASPAN 65 55 35 127
CLONIDINE HCL 65 45 35 39
CLOPIDOGREL 62 50 37 32
GABAPENTIN 62 47 37 13
FENOFIBRATE 61 37 39 56
GLIPIZIDE ER 58 58 40 86
METOPROLOL SUCCINATE 58 54 40 19
AMOX TR-POTASSIUM CLAVULANATE 57 42 42 118
TERAZOSIN HCL 57 57 42 142
CIPROFLOXACIN HCL 53 44 44 58
PROAIR HFA 52 40 45 69
JANUVIA 52 39 45 68
VICTOZA 3-PAK 51 34 47 337
ESCITALOPRAM OXALATE 51 49 47 74
PRAMIPEXOLE DIHYDROCHLORIDE 50 36 49 203
ADVAIR DISKUS 50 29 49 63
FLUOXETINE HCL 50 33 49 55
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 26, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.